Thomas G. Voss - Publications

Affiliations: 
Microbiology & Immunology Tulane University, New Orleans, LA, United States 
Area:
Virology Biology, Microbiology Biology

25 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Bangaru S, Zhang H, Gilchuk IM, Voss TG, Irving RP, Gilchuk P, Matta P, Zhu X, Lang S, Nieusma T, Richt JA, Albrecht RA, Vanderven HA, Bombardi R, Kent SJ, et al. A multifunctional human monoclonal neutralizing antibody that targets a unique conserved epitope on influenza HA. Nature Communications. 9: 2669. PMID 29991715 DOI: 10.1038/S41467-018-04704-9  0.439
2016 Yadav V, Panganiban AT, Honer Zu Bentrup K, Voss TG. Influenza infection modulates vesicular trafficking and induces Golgi complex disruption. Virusdisease. 27: 357-368. PMID 28004015 DOI: 10.1007/s13337-016-0347-3  0.376
2016 Lovalenti PM, Anderl J, Yee L, Nguyen V, Ghavami B, Ohtake S, Saxena A, Voss T, Truong-Le V. Stabilization of Live Attenuated Influenza Vaccines by Freeze Drying, Spray Drying, and Foam Drying. Pharmaceutical Research. PMID 26818839 DOI: 10.1007/S11095-016-1860-1  0.322
2016 Naveen S, Kannadka C, Chen M, Lin S, Nichols G, Patterson M, Kappes M, Voss T. Functional Dipeptidyl Peptidase 4 (DPP4) in mink supports entry and replication of Middle Eastern respiratory syndrome coronavirus: American Mink (Neovision vision), a novel in vivo model of MERS-CoV infection International Journal of Infectious Diseases. 45: 21. DOI: 10.1016/J.Ijid.2016.02.079  0.358
2014 Cross RW, Waffa B, Freeman A, Riegel C, Moses LM, Bennett A, Safronetz D, Fischer ER, Feldmann H, Voss TG, Bausch DG. Old World hantaviruses in rodents in New Orleans, Louisiana. The American Journal of Tropical Medicine and Hygiene. 90: 897-901. PMID 24639295 DOI: 10.4269/Ajtmh.13-0683  0.43
2014 Badani H, Garry RF, Voss TG, Wilson RB, Wimley WC. Mechanism of Action of Flufirvitide, a Peptide Inhibitor of Influenza Virus Infection Biophysical Journal. 106: 707a. DOI: 10.1016/J.Bpj.2013.11.3923  0.533
2012 Voss TG, Chen M, Nichols GJ, Naveen SK, Bradley BT, Cross RW. Dengue virus-pandemic influenza virus co-infection results in enhanced influenza virus replication through inhibition of apoptosis Retrovirology. 9. DOI: 10.1186/1742-4690-9-S1-O10  0.543
2010 Roy CJ, Voss TG. Use of the Aerosol Rabbitpox Virus Model for Evaluation of Anti-Poxvirus Agents. Viruses. 2: 2096-2107. PMID 20953322 DOI: 10.3390/V2092096  0.411
2010 Norton EB, Clements JD, Voss TG, Cárdenas-Freytag L. Prophylactic administration of bacterially derived immunomodulators improves the outcome of influenza virus infection in a murine model. Journal of Virology. 84: 2983-95. PMID 20053748 DOI: 10.1128/Jvi.01805-09  0.478
2009 Brocato RL, Voss TG. Pichinde virus induces microvascular endothelial cell permeability through the production of nitric oxide. Virology Journal. 6: 162. PMID 19814828 DOI: 10.1186/1743-422X-6-162  0.641
2008 See RH, Petric M, Lawrence DJ, Mok CP, Rowe T, Zitzow LA, Karunakaran KP, Voss TG, Brunham RC, Gauldie J, Finlay BB, Roper RL. Severe acute respiratory syndrome vaccine efficacy in ferrets: whole killed virus and adenovirus-vectored vaccines. The Journal of General Virology. 89: 2136-46. PMID 18753223 DOI: 10.1099/Vir.0.2008/001891-0  0.406
2008 LeBlanc C, Wilson R, Kulkosky P, Garry R, Voss T. Peptide-based Entry Inhibitors for Paramyxoviruses Antiviral Research. 78: A43. DOI: 10.1016/J.Antiviral.2008.01.084  0.341
2008 Voss T, LeBlanc C, Barbercheck J, Kaplan B, Wilson R, Robert G. Peptide-based Entry Inhibitors for Influenza Antiviral Research. 78: A18. DOI: 10.1016/J.Antiviral.2008.01.021  0.632
2007 VOSS T, WARFIELD K, BROCATO R, BARBERCHECK J, KAPLIN B, STEIN D, BAVARI S, IVERSEN P. Phosphorodiamidate Morpholino Oligomer—Mediated Inhibition of Influenza A Virus in Mice Antiviral Research. 74: A47-A47. DOI: 10.1016/J.Antiviral.2007.01.056  0.654
2006 See RH, Zakhartchouk AN, Petric M, Lawrence DJ, Mok CP, Hogan RJ, Rowe T, Zitzow LA, Karunakaran KP, Hitt MM, Graham FL, Prevec L, Mahony JB, Sharon C, Auperin TC, ... ... Voss TG, et al. Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus. The Journal of General Virology. 87: 641-50. PMID 16476986 DOI: 10.1099/Vir.0.81579-0  0.344
2005 Marciani DJ, Ptak RG, Voss TG, Reynolds RC, Pathak AK, Chamblin TL, Scholl DR, May RD. Corrigendum to “Degradation of Quillaja saponaria Molina saponins: Loss of the protective effects of a herpes simplex virus 1 subunit vaccine” [International Immunopharmacology 2/12 (2002) 1703–1711] International Immunopharmacology. 5: 1658. DOI: 10.1016/J.Intimp.2005.05.002  0.436
2004 Hogan RJ, Gao G, Rowe T, Bell P, Flieder D, Paragas J, Kobinger GP, Wivel NA, Crystal RG, Boyer J, Feldmann H, Voss TG, Wilson JM. Resolution of primary severe acute respiratory syndrome-associated coronavirus infection requires Stat1. Journal of Virology. 78: 11416-21. PMID 15452265 DOI: 10.1128/Jvi.78.20.11416-11421.2004  0.415
2004 Liu G, Zhai Q, Schaffner DJ, Wu A, Yohannes A, Robinson TM, Maland M, Wells J, Voss TG, Bailey C, Alibek K. Prevention of lethal respiratory vaccinia infections in mice with interferon-alpha and interferon-gamma. Fems Immunology and Medical Microbiology. 40: 201-6. PMID 15039095 DOI: 10.1016/S0928-8244(03)00358-4  0.35
2004 Buckwold VE, Wilson RJ, Nalca A, Beer BB, Voss TG, Turpin JA, Buckheit RW, Wei J, Wenzel-Mathers M, Walton EM, Smith RJ, Pallansch M, Ward P, Wells J, Chuvala L, et al. Antiviral activity of hop constituents against a series of DNA and RNA viruses. Antiviral Research. 61: 57-62. PMID 14670594 DOI: 10.1016/S0166-3542(03)00155-4  0.441
2002 Marcian DJ, Ptak RG, Voss TG, Reynolds RC, Pathak AK, Chamblin TL, Scholl DR, May RD. Degradation of Quillaja saponaria Molina saponins: loss of the protective effects of a herpes simplex virus 1 subunit vaccine. International Immunopharmacology. 2: 1703-11. PMID 12469944 DOI: 10.1016/S1567-5769(02)00192-3  0.358
2000 Baghian A, Luftig M, Black JB, Meng YX, Pau CP, Voss T, Pellett PE, Kousoulas KG. Glycoprotein B of human herpesvirus 8 is a component of the virion in a cleaved form composed of amino- and carboxyl-terminal fragments. Virology. 269: 18-25. PMID 10725194 DOI: 10.1006/Viro.2000.0198  0.335
1996 Makutonina A, Voss TG, Plymale DR, Fermin CD, Norris CH, Vigh S, Garry RF. Human immunodeficiency virus infection of T-lymphoblastoid cells reduces intracellular pH. Journal of Virology. 70: 7049-55. PMID 8794349 DOI: 10.1128/Jvi.70.10.7049-7055.1996  0.359
1996 Voss TG, Fermin CD, Levy JA, Vigh S, Choi B, Garry RF. Alteration of intracellular potassium and sodium concentrations correlates with induction of cytopathic effects by human immunodeficiency virus. Journal of Virology. 70: 5447-54. PMID 8764056 DOI: 10.1128/Jvi.70.8.5447-5454.1996  0.359
1996 Voss TG, Gatti PJ, Fermin CD, Garry RF. Reduction of human immunodeficiency virus production and cytopathic effects by inhibitors of the Na+/K+/2Cl- cotransporter. Virology. 219: 291-4. PMID 8623543 DOI: 10.1006/Viro.1996.0249  0.319
1992 Wyde PR, Ambrose MW, Voss TG, Meyer HL, Gilbert BE. Measles virus replication in lungs of hispid cotton rats after intranasal inoculation. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 201: 80-7. PMID 1528912 DOI: 10.3181/00379727-201-43483  0.418
Show low-probability matches.